Terms: = Leukemia AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Treatment
303 results:
1. BCL-X
Jenkins LJ; Luk IY; Chionh F; Tan T; Needham K; Ayton J; Reehorst CM; Vukelic N; Sieber OM; Mouradov D; Gibbs P; Williams DS; Tebbutt NC; Desai J; Hollande F; Dhillon AS; Lee EF; Merino D; Fairlie WD; Mariadason JM
Cell Death Dis; 2024 Mar; 15(3):183. PubMed ID: 38429301
[TBL] [Abstract] [Full Text] [Related]
2. [Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia].
Dou XL; Liu RX; Liu Y; Peng N; Wen L; Wu Y; Li Q; Zhong YP; Zhou X; Liao AJ; Jiang HN; Ma XJ; Dong HH; Fan SJ; Zhao YQ; Hu DH; Lu J
Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):499-506. PubMed ID: 38317361
[No Abstract] [Full Text] [Related]
3. Osimertinib Covalently Binds to CD34 and Eliminates Myeloid leukemia Stem/Progenitor Cells.
Xia L; Liu JY; Yang MY; Zhang XH; Jiang Y; Yin QQ; Luo CH; Liu HC; Kang ZJ; Zhang CT; Gao BB; Zhou AW; Cai HY; Waller EK; Yan JS; Lu Y
Cancer Res; 2024 Feb; 84(3):479-492. PubMed ID: 38095536
[TBL] [Abstract] [Full Text] [Related]
4. erbb4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.
Arribas AJ; Napoli S; Cascione L; Barnabei L; Sartori G; Cannas E; Gaudio E; Tarantelli C; Mensah AA; Spriano F; Zucchetto A; Rossi FM; Rinaldi A; Castro de Moura M; Jovic S; Bordone Pittau R; Stathis A; Stussi G; Gattei V; Brown JR; Esteller M; Zucca E; Rossi D; Bertoni F
Mol Cancer Ther; 2024 Mar; 23(3):368-380. PubMed ID: 38052765
[TBL] [Abstract] [Full Text] [Related]
5. The prevalence of anemia in people with chronic kidney disease after hematopoietic stem cell transplantation.
Kępska-Dzilińska M; Karakulska-Prystupiuk E; Kaszyńska A; Basak GW; Małyszko J
Ren Fail; 2023; 45(2):2263581. PubMed ID: 37782282
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations.
More P; Ngaffo JAM; Goedtel-Armbrust U; Hähnel PS; Hartwig UF; Kindler T; Wojnowski L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629110
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through egfr/AKT and Wnt/β-catenin signaling.
Tang Z; Yang Y; Chen W; Liang T
Hepatol Commun; 2023 Aug; 7(8):. PubMed ID: 37486965
[TBL] [Abstract] [Full Text] [Related]
8. Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States.
Roskoski R
Pharmacol Res; 2023 Aug; 194():106847. PubMed ID: 37454916
[TBL] [Abstract] [Full Text] [Related]
9. c-Met is a chimeric antigen receptor T-cell target for treating recurrent nasopharyngeal carcinoma.
Huo Q; Lv J; Zhang J; Huang H; Hu H; Zhao Y; Zhang X; Wang Y; Zhou Y; Qiu J; Ye Y; Huang A; Chen Y; Qin L; Qin D; Li P; Cai G
Cytotherapy; 2023 Oct; 25(10):1037-1047. PubMed ID: 37436338
[TBL] [Abstract] [Full Text] [Related]
10. The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2/M arrest via downregulation of MEK1/2 phosphorylation in leukemia cells.
Zhou M; Boulos JC; Klauck SM; Efferth T
Cell Biol Toxicol; 2023 Dec; 39(6):2971-2997. PubMed ID: 37322258
[TBL] [Abstract] [Full Text] [Related]
11. Osimertinib is a dual inhibitor of hepatocellular carcinoma and angiogenesis in an egfr-independent manner, and synergizes with venetoclax.
Huang Q; He S; Zhan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10727-10735. PubMed ID: 37310474
[TBL] [Abstract] [Full Text] [Related]
12. Mechanism of Procyanidin B2 in the treatment of Chronic Myeloid leukemia Based on Integrating Network Pharmacology and Molecular Docking.
Li HX; Jing YX; Chai YH; Sun XH; He XX; Xue SL; Xi YM; Ma XL
Anticancer Agents Med Chem; 2023; 23(16):1838-1847. PubMed ID: 37246327
[TBL] [Abstract] [Full Text] [Related]
13. Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma.
Goda C; Kolovich S; Rudich A; Karunasiri M; Kulkarni R; Rajgolikar G; Neidemire-Colley L; Singh S; Sircar A; Ranganathan P; Garzon R; Sehgal L; Dorrance AM
Exp Hematol; 2023 Jul; 123():28-33.e3. PubMed ID: 37209901
[TBL] [Abstract] [Full Text] [Related]
14. CUDC-101 as a dual-target inhibitor of egfr and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest.
Cao W; Yao S; Li A; Chen H; Zhang E; Cao L; Zhang J; Hou Y; Dai Z; Chen J; Huang X; Yang L; Cai Z
J Zhejiang Univ Sci B; 2023 May; 24(5):442-454. PubMed ID: 37190893
[TBL] [Abstract] [Full Text] [Related]
15. Exploring underlying mechanism of artesunate in treatment of acute myeloid leukemia using network pharmacology and molecular docking.
Tao Y; Li W; Yang J; Xue T; Wang Y; Dong X; Xu H; Ren J; Lu J
Clin Transl Oncol; 2023 Aug; 25(8):2427-2437. PubMed ID: 36952106
[TBL] [Abstract] [Full Text] [Related]
16. Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice.
Youssef ME; Cavalu S; Hasan AM; Yahya G; Abd-Eldayem MA; Saber S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902446
[TBL] [Abstract] [Full Text] [Related]
17. Curcumol Exerts Antitumor Effect via Inhibiting egfr-Akt-Mcl-1 Signaling.
Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
[TBL] [Abstract] [Full Text] [Related]
18. Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer.
Leto SM; Ferri M; Sassi F; Zanella ER; Cottino F; Vurchio V; Catalano I; Ferrero A; Zingaretti CC; Marchiò C; Grassi E; Trusolino L; Bertotti A
Clin Cancer Res; 2023 Mar; 29(6):1102-1113. PubMed ID: 36622698
[TBL] [Abstract] [Full Text] [Related]
19. Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia.
Chen Y; Shao X; Yang H; Ren L; Cui Y; Zhang W; Macip S; Meng X
Eur J Haematol; 2023 Apr; 110(4):435-443. PubMed ID: 36576398
[TBL] [Abstract] [Full Text] [Related]
20. Lupane Triterpene Derivatives Improve Antiproliferative Effect on leukemia Cells through Apoptosis Induction.
Valencia-Chan LS; Estrada-Alfaro N; Ceballos-Cruz JJ; Torres-Tapia LW; Peraza-Sánchez SR; Moo-Puc RE
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500355
[TBL] [Abstract] [Full Text] [Related]
[Next]
